References
- Collins JF, Lieberman DA, Durbin TE, et al (2005). Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice. Ann Intern Med, 142, 81-5. https://doi.org/10.7326/0003-4819-142-2-200501180-00006
- Corte H, Manceau G, Blons H, et al (2012). MicroRNA and colorectal cancer. Dig Liver Dis, 44, 195-200. https://doi.org/10.1016/j.dld.2011.10.010
- Deeks JJ, Macaskill P, Irwig L (2005). The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol, 58, 882-93. https://doi.org/10.1016/j.jclinepi.2005.01.016
- Deville WL, Buntinx F, Bouter LM, et al (2002). Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol, 2, 9. https://doi.org/10.1186/1471-2288-2-9
- Gallagher EJ. (1998). Clinical utility of likelihood ratios. Ann Emerg Med, 31, 391-7. https://doi.org/10.1016/S0196-0644(98)70352-X
- Giraldez MD, Lozano JJ, Ramirez G, et al (2013). Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study. Clin Gastroenterol Hepatol, 11, 681-8 e3. https://doi.org/10.1016/j.cgh.2012.12.009
- Glas AS, Lijmer JG, Prins MH, et al (2003). The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol, 56, 1129-35. https://doi.org/10.1016/S0895-4356(03)00177-X
- Higgins JP, Thompson SG, Deeks JJ, et al (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60. https://doi.org/10.1136/bmj.327.7414.557
- Huang Z, Huang D, Ni S, et al (2010). Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer, 127, 118-26. https://doi.org/10.1002/ijc.25007
- Jemal A, Siegel R, Xu J, et al (2010). Cancer statistics, 2010. CA Cancer J Clin, 60, 277-300. https://doi.org/10.3322/caac.20073
- Kalimutho M, Del Vecchio Blanco G, Di Cecilia S, et al (2011). Differential expression of miR-144* as a novel fecal-based diagnostic marker for colorectal cancer. J Gastroenterol, 46, 1391-402. https://doi.org/10.1007/s00535-011-0456-0
- Kanaan Z, Rai SN, Eichenberger MR, et al (2012). Plasma miR-21: a potential diagnostic marker of colorectal cancer. Ann Surg, 256, 544-51. https://doi.org/10.1097/SLA.0b013e318265bd6f
- Koga Y, Yasunaga M, Takahashi A, et al (2010). MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening. Cancer Prev Res (Phila), 3, 1435-42. https://doi.org/10.1158/1940-6207.CAPR-10-0036
- Lansdorp-Vogelaar I, Kuntz KM, Knudsen AB, et al (2010). Stool DNA testing to screen for colorectal cancer in the Medicare population: a cost-effectiveness analysis. Ann Intern Med, 153, 368-77. https://doi.org/10.7326/0003-4819-153-6-201009210-00004
- Levin B, Lieberman DA, McFarland B, et al (2008). Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin, 58, 130-60. https://doi.org/10.3322/CA.2007.0018
- Liu K, Li G, Fan C, et al (2011). Increased expression of microRNA-21and its association with chemotherapeutic response in human colorectal cancer. J Int Med Res, 39, 2288-95. https://doi.org/10.1177/147323001103900626
- Mandel JS (2008). Screening for colorectal cancer. Gastroenterol Clin North Am, 37, 97-115, vii. https://doi.org/10.1016/j.gtc.2007.12.007
- Mitchell PS, Parkin RK, Kroh EM, et al (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A, 105, 10513-8. https://doi.org/10.1073/pnas.0804549105
- Ng EK, Chong WW, Jin H, et al (2009). Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut, 58, 1375-81. https://doi.org/10.1136/gut.2008.167817
- O’Connell JB, Maggard MA, Ko CY (2004). Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst, 96, 1420-5. https://doi.org/10.1093/jnci/djh275
- Pu XX, Huang GL, Guo HQ, et al (2010). Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression. J Gastroenterol Hepatol, 25, 1674-80. https://doi.org/10.1111/j.1440-1746.2010.06417.x
- Reitsma JB, Glas AS, Rutjes AW, et al (2005). Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol, 58, 982-90. https://doi.org/10.1016/j.jclinepi.2005.02.022
- Schetter AJ, Leung SY, Sohn JJ, et al (2008). MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA, 299, 425-36.
- Schetter AJ, Nguyen GH, Bowman ED, et al (2009). Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma. Clin Cancer Res, 15, 5878-87. https://doi.org/10.1158/1078-0432.CCR-09-0627
- Wang B, Zhang Q (2012). The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors. J Cancer Res Clin Oncol, 138, 1659-66. https://doi.org/10.1007/s00432-012-1244-9
- Wang Q, Huang Z, Ni S, et al (2012). Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer. PLoS One, 7, e44398. https://doi.org/10.1371/journal.pone.0044398
- Wang S, Wang L, Bayaxi N, et al (2013a). A microRNA panel to discriminate carcinomas from high-grade intraepithelial neoplasms in colonoscopy biopsy tissue. Gut, 62, 280-9. https://doi.org/10.1136/gutjnl-2011-301554
- Wang S, Xiang J, Li Z, et al (2013b). A plasma microRNA panel for early detection of colorectal cancer. Int J Cancer.
- Whiting P, Rutjes AW, Reitsma JB, et al (2003). The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol, 3, 25. https://doi.org/10.1186/1471-2288-3-25
- Whiting P, Rutjes AW, Reitsma JB, et al (2004). Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Ann Intern Med, 140, 189-202. https://doi.org/10.7326/0003-4819-140-3-200402030-00010
- Wu CW, Ng SS, Dong YJ, et al (2012). Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps. Gut, 61, 739-45. https://doi.org/10.1136/gut.2011.239236
- Zhang B, Pan X, Cobb GP, et al (2007). MicroRNAs as oncogenes and tumor suppressors. Dev Biol, 302, 1-12. https://doi.org/10.1016/j.ydbio.2006.08.028
- Zhou T, Zhang G, Liu Z, et al (2013). Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer. Int J Colorectal Dis, 28, 19-24. https://doi.org/10.1007/s00384-012-1528-1
Cited by
- MicroRNAs as Promising Biomarkers for Tumor-staging: Evaluation of MiR21 MiR155 MiR29a and MiR92a in Predicting Tumor Stage of Rectal Cancer vol.15, pp.13, 2014, https://doi.org/10.7314/APJCP.2014.15.13.5175
- MicroRNAs in Colorectal Cancer: from Diagnosis to Targeted Therapy vol.15, pp.17, 2014, https://doi.org/10.7314/APJCP.2014.15.17.6989
- Epidemiology and screening: what's new? vol.17, pp.14628910, 2014, https://doi.org/10.1111/codi.12815
- Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in colorectal cancer vol.31, pp.10, 2014, https://doi.org/10.1007/s12032-014-0235-x
- Circulating miR-222 in plasma and its potential diagnostic and prognostic value in gastric cancer vol.31, pp.9, 2014, https://doi.org/10.1007/s12032-014-0164-8
- The role of circulating microRNAs as novel biomarkers in diagnosing colorectal cancer vol.27, pp.7, 2015, https://doi.org/10.1097/MEG.0000000000000363
- The expression and clinical significance of microRNAs in colorectal cancer detecting vol.36, pp.4, 2015, https://doi.org/10.1007/s13277-014-2890-0
- Influence of miR-155 on Cell Apoptosis in Rats with Ischemic Stroke: Role of the Ras Homolog Enriched in Brain (Rheb)/mTOR Pathway vol.22, pp.1643-3750, 2016, https://doi.org/10.12659/MSM.898980